Anti-HPV31 E7抗體,人類乳頭狀瘤病毒31 E7抗體說明書產品詳細資料

產品編號 BYK-10203R

英文名稱 HPV31 E7
中文名稱 人類乳頭狀瘤病毒31 E7抗體
別    名 VE7_HPV31; Protein E7; E7; Human Papilloma Virus; Human papillomavirus type 31 E7; Human papillomavirus type 31 (E7); Human papillomavirus type 31 E7; Human papillomavirus type 31 E7 protein; Protein E7; HPV31 E7 protein.
研究領域 腫瘤  免疫學  細菌及病毒  
分 子 量 11kDa

抗體來源 Mouse or Rabbit
克隆類型 Monoclonal or Polyclonal
產品應用 WB、ELISA、IHC-P、IHC-F、Flow-Cyt、IF、IP、ICC 此產品應用不做依據，具體產品應用與實驗稀釋比請！

not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.

性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
亞    型 IgG
純化方法 affinity purified by Protein G
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4℃.


     Anti-HPV31 E7抗體,人類乳頭狀瘤病毒31 E7抗體說明書產品介紹 

      Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximay 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis have shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro. Human papillomaviruses (HPV) are small DNA viruses which infect epithelia of the skin and mucosa. Over 90 types have been identified and they mostly cause a variety of benign lesions such as warts and verrucae. However, some subtypes, notably types 16 and 18, 31 and 33, have been confirmed as agents which cause cervical cancer.

 此相關標記有：Alexa Fluor 350 標記、Alexa Fluor 488 標記、Alexa Fluor 555 標記、Alexa Fluor 647 標記、AP標記、APC標記、Biotin標記、Cy3標記、Cy5標記、Cy5.5標記、Cy7標記、FITC標記、Gold標記、HRP標記、PE標記、PE-Cy3標記、PE-CY5標記、PE-CY5.5標記、PE-CY7標記、RBITC標記 

     相關產品：

     Anti-GPR84抗體,G蛋白偶聯受體84抗體

Anti-GPCR G2A抗體,G蛋白偶聯受體G2A抗體
Anti-GPR1抗體,G蛋白偶聯受體1抗體
Anti-GPR100抗體,G蛋白偶聯受體100抗體
Anti-GPR12抗體,G蛋白偶聯受體12抗體
Anti-GPR124抗體,腫瘤血管內皮標志物/G蛋白偶聯受體124抗體
Anti-GPR125抗體,G蛋白偶聯受體125抗體
Anti-GPR146抗體,G蛋白偶聯受體146抗體
Anti-GPR17抗體,G蛋白偶聯受體17抗體
Anti-GPR19/GPR4抗體,G蛋白偶聯受體19/GPCR GPR4抗體
Anti-GPR20抗體,G蛋白偶聯受體20抗體
Anti-GPR22抗體,G蛋白偶聯受體22抗體
Anti-GPR26抗體,G蛋白偶聯受體26抗體
Anti-GPR3抗體,G蛋白偶聯受體3抗體
Anti-GPR31抗體,G蛋白偶聯受體31抗體
Anti-GPR34抗體,G蛋白偶聯受體34抗體
Anti-Guanylyl Cyclase alpha 1抗體,鳥苷酸環化酶α1/GCS-α1抗體
Anti-GPR7抗體,G蛋白偶聯受體7抗體
Anti-GPCR C5L2抗體,G蛋白偶聯受體C5L2蛋白抗體
Anti-GPCR EX33抗體,G蛋白偶聯受體EX33蛋白抗體